Cell-specific restriction of influenza A virus assembly

NIH RePORTER · NIH · R21 · $227,440 · view on reporter.nih.gov ↗

Abstract

Project Summary/Abstract The influenza A virus continues to be a major cause of morbidity and mortality worldwide despite implementation of vaccines and a few antiviral drugs. Our long-term goal is to determine the molecular mechanisms regulating assembly and spread of influenza A virus, which potentially serve as new targets for antivirals. In the current proposal, our objective is to determine the mechanism that gives rise to the cell type- specific differences in infectious virus assembly. The Influenza A virus can infect macrophages, but macrophages are much less permissive than airway epithelial cells. Our preliminary studies showed that infectious titer release from human primary monocyte-derived macrophages (MDMs) is severely impaired relative to differentiated THP-1, a human monocytic cell line. Using correlative fluorescence and scanning microscopy further revealed that efficient assembly of virus particles at the plasma membrane is detectable in differentiated THP-1 but not in MDMs even though both differentiated THP-1 and primary MDM express viral structural proteins at the cell surface to the same extent. The expression levels of total viral RNA and proteins are also similar. These results indicate that assembly of progeny virus particles is highly inefficient in human primary macrophages. Interestingly, we observed that influenza transmembrane proteins HA and M2, both of which plays key roles in virus assembly and release, fail to come in close proximity of each other in MDMs but not in differentiated THP-1 or epithelial cells and that this restriction in MDMs is reversed upon disruption of actin cytoskeleton. Based on these and other preliminary results, in this proposal we plan to test our central hypothesis that actin cytoskeletons restrict influenza A virus assembly via modulation of viral protein distribution at the plasma membrane in a cell-dependent manner. We will first identify viral structural proteins that render the virus susceptible to this inhibition of HA-M2 association (Aim 1). Then, we will determine the cellular mechanism that contributes to this inhibition (Aim 2). The rationale behind focusing on cell-specific differences in influenza virus assembly and release is to facilitate identification of cellular mechanisms that support or inhibit influenza virus propagation. Once identified, such mechanisms may serve as potential targets for therapeutic modulation designed to block virus spread in the respiratory epithelial cells.

Key facts

NIH application ID
9833492
Project number
5R21AI143276-02
Recipient
UNIVERSITY OF MICHIGAN AT ANN ARBOR
Principal Investigator
Akira Ono
Activity code
R21
Funding institute
NIH
Fiscal year
2020
Award amount
$227,440
Award type
5
Project period
2018-12-07 → 2021-11-30